Melanoma Awareness
This year many of us were confined to staying home because of the coronavirus pandemic, and although life may be…
Telehealth Digital Assisted Surgical Planning
Since the onset of COVID-19, our team at the Saint John’s Cancer Institute, continued to meet the needs of our…
Men’s Health Awareness
To all the men out there…this one’s for you! The month of June has been deemed “Men’s Health Month” and…
Making Advancements in Cancer Treatments
The Translational Neurosciences department at the Saint John’s Cancer Institute is committed to accelerate the development of novel therapies for…
NEW Bladder Cancer Treatments Approved by FDA
We have some exciting news to announce! Thanks to the participation of Saint John’s Cancer Institute and our proactive approach…
A message from the CEO of Saint John’s Health Center
Dear Valued Patient, We want to share some important information that could be beneficial to your health and wellbeing. On April…
Life Saving COVID-19 Research
The Saint John’s Cancer Institute is searching for a safe and effective treatment for COVID-19. Under the leadership of Dr….
COVID-19 Clinical Trial Success Story: “Code Victory” for LAPD Officer
As many of us are still at home under quarantine or working under difficult conditions as an essential employee, we…
Coronavirus Mask FAQs – Here is What You Need to Know
The Coronavirus pandemic is requiring all of us to find ways to protect ourselves. So much information is coming out…
First COVID-19 Patient Treated Under Emergency Use IND At Providence Saint John’s Health Center
Originally published: https://www.biospace.com/article/releases/first-covid-19-patient-treated-under-emergency-use-ind-at-providence-saint-john-s-health-center-using-stemedica-ischemia-tolerant-allogeneic-mesenchymal-bone-marrow-cells/ SANTA MONICA, Calif., April 20, 2020 /PRNewswire/ — A single patient, emergency Investigational New Drug (IND) use was cleared by…